Sera Prognostics-a logo

Sera Prognostics-a share price today

(SERA)

Sera Prognostics-a share price is $8.78 & ₹746.09 as on 21 Dec 2024, 2.30 'hrs' IST

$8.78

0.65

(8%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Sera Prognostics-a share price in Dollar and Rupees. Guide to invest in Sera Prognostics-a from India. Also see the sentimental analysis on Indian investors investing in Sera Prognostics-a. Get details on the Indian mutual funds that are investing in Sera Prognostics-a. Get Analyst recommendations and forecasts along with all the Sera Prognostics-a's financials.

Sera Prognostics-a share price movements

  • Today's Low: $8.07
    Today's High: $8.85

    Day's Volatility :8.81%

  • 52 Weeks Low: $4.90
    52 Weeks High: $12.36

    52 Weeks Volatility :60.34%

Sera Prognostics-a Returns

PeriodSera Prognostics Inc-aSector (Health Care)Index (Russel 2000)
3 Months
21.94%
-11.1%
0.0%
6 Months
35.49%
-6.0%
0.0%
1 Year
33.23%
2.7%
0.0%
3 Years
14.62%
0.6%
-19.7%

Sera Prognostics-a Key Statistics

in dollars & INR

Previous Close
$8.13
Open
$8.07
Today's High
$8.85
Today's Low
$8.07
Market Capitalization
$274.6M
Today's Volume
$177.8K
52 Week High
$12.355
52 Week Low
$4.9
Revenue TTM
$94.0K
EBITDA
$-35.2M
Earnings Per Share (EPS)
$-0.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-49.58%

How to invest in Sera Prognostics-a from India?

It is very easy for Indian residents to invest directly in Sera Prognostics-a from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sera Prognostics-a stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sera Prognostics-a or SERA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sera Prognostics-a or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sera Prognostics-a shares which would translate to 0.097 fractional shares of Sera Prognostics-a as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Sera Prognostics-a, in just a few clicks!

Returns in Sera Prognostics-a for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sera Prognostics-a investment value today

Current value as on today

₹1,35,428

Returns

₹35,428

(+35.43%)

Returns from Sera Prognostics-a Stock

₹33,232 (+33.23%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Sera Prognostics-a

100%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Sera Prognostics-a on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 100% more investors are searching Sera Prognostics-a in the last 30 days versus the previous period.

Global Institutional Holdings in Sera Prognostics-a

  • Baker Bros Advisors LP

    16.09%

  • RA Capital Management, LLC

    8.98%

  • Vivo Capital, LLC

    4.89%

  • BlackRock Inc

    4.17%

  • Vanguard Group Inc

    3.55%

  • JPMorgan Chase & Co

    2.62%

Analyst Recommendation on Sera Prognostics-a

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Sera Prognostics-a(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Sera Prognostics-a

What analysts predicted

Downside of 68.68%

Current:

$8.78

Target:

$2.75

Insights on Sera Prognostics-a

  • Price Movement

    In the last 1 month, SERA stock has moved up by 43.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 24.0K → 29.0K (in $), with an average increase of 17.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -8.30M → -7.91M (in $), with an average increase of 4.9% per quarter
  • SERA vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 59.8% return, outperforming this stock by 27.8%
  • SERA vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 116.4% return, outperforming this stock by 106.2%
  • Price to Sales

    ForSERA every $1 of sales, investors are willing to pay $2926.7, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Sera Prognostics-a Technicals Summary

Sell

Neutral

Buy

Sera Prognostics-a is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sera Prognostics-a Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Sera Prognostics Inc-a
43.7%
35.49%
33.23%
14.62%
-26.22%
Stryker Corporation
-6.55%
7.53%
22.55%
38.08%
71.54%
Boston Scientific Corp.
-2.79%
15.96%
59.12%
110.98%
96.7%
Edwards Lifesciences Corp.
6.29%
-17.03%
-1.35%
-41.48%
-5.43%
Abbott Laboratories
-2.58%
8.48%
4.77%
-17.81%
30.77%
Medtronic Plc
-4.38%
-0.01%
-1.09%
-20.04%
-28.85%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Sera Prognostics Inc-a
NA
NA
NA
-0.97
-0.5
-0.27
NA
1.62
Stryker Corporation
38.32
38.32
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.27
73.27
1.61
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.88
28.88
6.79
2.55
0.19
0.11
NA
16.18
Abbott Laboratories
34.17
34.17
2.17
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.46
24.46
1.46
5.2
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Sera Prognostics Inc-a
Buy
$274.6M
-26.22%
NA
0.0%
Stryker Corporation
Buy
$136.1B
71.54%
38.32
16.34%
Boston Scientific Corp.
Buy
$130.7B
96.7%
73.27
11.26%
Edwards Lifesciences Corp.
Buy
$44.1B
-5.43%
28.88
65.86%
Abbott Laboratories
Buy
$195.0B
30.77%
34.17
13.99%
Medtronic Plc
Buy
$102.6B
-28.85%
24.46
12.06%

About Sera Prognostics-a

sera prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. sera’s tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health. the company has assembled a strong management team and board of directors with significant clinical development and women’s healthcare diagnostic experience. the company is supported by a strong group of investors, including the bill & melinda gates foundation, chione, ltd, domain associates, interwest partners, catalyst health ventures, upstart life sciences capital, and osage university partners. the company is working with the bill & melinda gates foundation to translate its discoveries and develop technologies to benefit women and infants in underserved countries worldwide. sera prognostics is located in salt lake city, utah. sera launched its first diagnos
Organization
Sera Prognostics-a
Employees
55
CEO
Ms. Evguenia Lindgardt M.B.A.
Industry
Services

Management People of Sera Prognostics-a

NameTitle
Ms. Evguenia Lindgardt M.B.A.
President, CEO & Director
Mr. Austin Aerts
Chief Financial Officer
Dr. John J. Boniface Ph.D.
Chief Scientific Officer
Dr. Gregory C. Critchfield M.D., M.S.
Executive Director
Mr. Robert G. Harrison
Chief Information Officer
Mr. Benjamin G. Jackson J.D.
General Counsel
Dr. Paul Kearney Ph.D.
Chief Data Officer

Important FAQs about investing in Sera Prognostics-a from India :

What is Sera Prognostics-a share price today?

Sera Prognostics-a share price today stands at $8.78, Open: $8.07 ; Previous Close: $8.13 ; High: $8.85 ; Low: $8.07 ; 52 Week High: $12.36 ; 52 Week Low: $4.90. The stock opens at $8.07, after a previous close of $8.13. The stock reached a daily high of $8.85 and a low of $8.07, with a 52-week high of $12.36 and a 52-week low of $4.90.

Can Indians buy Sera Prognostics-a shares?

Yes, Indians can invest in the Sera Prognostics-a (SERA) from India.

With INDmoney, you can buy Sera Prognostics-a at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sera Prognostics-a at zero transaction cost.

How can I buy Sera Prognostics-a shares from India?

It is very easy to buy Sera Prognostics-a from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sera Prognostics-a be purchased?

Yes, you can buy fractional shares of Sera Prognostics-a with INDmoney app.

What are the documents required to start investing in Sera Prognostics-a stocks?

To start investing in Sera Prognostics-a, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sera Prognostics-a

Today’s highest price of Sera Prognostics-a (SERA) is $8.85.

Today’s lowest price of Sera Prognostics-a (SERA) is $8.07.

What is today's market capitalisation of Sera Prognostics-a

Today's market capitalisation of Sera Prognostics-a SERA is 274.6M

What is the 52 Week High and Low Range of Sera Prognostics-a

  • 52 Week High

    $12.36

  • 52 Week Low

    $4.90

What are the historical returns of Sera Prognostics-a?

  • 1 Month Returns

    43.7%

  • 3 Months Returns

    35.49%

  • 1 Year Returns

    33.23%

  • 5 Years Returns

    -26.22%

Who is the Chief Executive Officer (CEO) of Sera Prognostics-a

Ms. Evguenia Lindgardt M.B.A. is the current Chief Executive Officer (CEO) of Sera Prognostics-a.